Our work aims to further evaluate significance of HSD11B1 expression in ccRCC prognosis and the correlation with clinicopathological characteristics using TCGA data and in vitro experiments, thereby providing additional evidence of HSD11B1 as a prognostic biomarker associated with immune cell infiltration in ccRCC. The gene discussed is HSD11B1; the disease is nonpapillary renal cell carcinoma.